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Abstract: A new series of betulin derivatives containing one or two pharmacophores 
bearing an acetylenic and carbonyl function at the C-3 and/or C-28 positions has been 
synthesized and characterized by 1H- and 13C-NMR, IR, MS and elemental analyses. The 
crystal structure of 28-O-propynoylbetulin was determined by X-ray structural analysis. 
All new compounds, as well as betulin, were tested in vitro for their antiproliferative 
activity against human SW707 colorectal, CCRF/CEM leukemia, T47D breast cancer, and 
against murine P388 leukemia and Balb3T3 normal fibroblasts cell lines. Most of the 
compounds showed better cytotoxicity than betulin and cisplatin used as reference agent. 
28-O-Propynoylbetulin was the most potent derivative, being over 500 times more potent 
than betulin and about 100 times more cytotoxic than cisplatin against the human leukemia 
(CCRF/CEM) cell line, with an ID50 value of 0.02 μg/mL. 
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1. Introduction 
Betulin [lup-20(29)-ene-3,28-diol, C30H50O2, 1] also known as betulinic alcohol, is a pentacyclic 
triterpene of the lupane type which was one of the first natural products identified and isolated from 
plants as a pure chemical substance in 1788 by Lowitz [1]. The still growing interest in betulin (1) and 
its derivatives results from their wide spectrum of biological activities such as anticancer, antiviral, 
anti-inflammatory, antibacterial and hepatoprotective properties [2–4]. Despite the fact that betulin (1) 
has been known for over 200 years, the X-ray crystal structure of this compound was investigated for 
the first time in 2010 by Drebushchak and in 2011 by Boryczka as betulin-EtOH and betulin-DMSO 
solvates, respectively [5,6]. Betulin (1) has three available sites for simple chemical modification, 
namely the secondary hydroxyl group at position C-3, the primary hydroxyl group at position C-28 
and the isopropenyl side chain at position C-19. 
Compound 1 can be easily converted in high yield to betulinic acid (2), which possesses a wide 
spectrum of biological and pharmacological activities and is now a very attractive and promising agent 
for clinical treatment for various types of cancer [7–9]. The chemical structures of these two 
compounds differ only in one group at C-17 [betulin (1) R=CH2OH, betulinic acid (2) R=COOH], and 
they are shown in Figure 1. In contrast to 2, betulin (1) has been described as inactive or less active 
against cancer cells [3,10]. However, the results of recent reports suggest that betulin (1) shows a 
significant cytotoxic activity in a similar way as betulinic acid (2) [11,12]. 
Figure 1. Structure of betulin (1) and betulinic acid (2). 
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The high content of betulin (1) in white birch bark (up to 30%) compared to betulinic acid (2)  
(up to 2.5%), make it an important starting material for synthesis of new compounds with various 
interesting medical properties. In the last few years a large number of betulin derivatives have been 
reported to possess anticancer, anti-inflammatory, anti-HIV and anti-leishmanial activity [2,13–16]. 
It is well known that the carbon-carbon triple bond is one of the most important functional groups 
in medicinal and organic chemistry [17]. Nevertheless, only a few reports have been described the 
synthesis of acetylenic derivatives of betulin which possess useful biological activity such as cytotoxic 
and antiviral properties [18–22]. It is interesting to note that the presence of an alkynyl group offers a 
possibility for further functionalization of betulins [23,24]. 
As an extension of our study on the development of novel acetylenic derivatives with potential 
anticancer activity [25,26], we became interested in the synthesis and evaluation of cytotoxicity of new 
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derivatives of betulin containing one or two pharmacophores including both carbonyl group and a 
triple bond at the C-3 and/or C-28 positions. In order to investigate structure-activity relationships for 
the anticancer effects, two types of reagents were used for modifications of the hydroxyl groups of 
betulin (1), namely acetylene chloroformate and propynoic acids. All new synthesized compounds 
were tested for cytotoxic activity against human: breast cancer (T47D), leukemia (CCRF/CEM), 
colorectal adenocarcinoma (SW707), and murine: leukemia (P388) as well as normal fibroblasts 
(Balb3T3) cell lines in order to obtain more information about the influence of triple bond and 
carbonyl group on anticancer activity in this class of compounds.  
2. Results and Discussion 
2.1. Chemistry 
Synthesis of acetylenic derivatives of betulin 3–9 was accomplished starting with betulin (1). 
Compound 1 was isolated from birch bark by extraction with dichloromethane. The crude betulin (1) 
was purified by column chromatography using a mixture of chloroform and ethanol as an eluent. Full 
structural elucidation of the betulin (1) was performed using 1H- and 13C-NMR and IR spectroscopy, 
and the assignments were done based on our analysis and related literature [6,27]. The synthesis of 
acetylenic derivatives of betulin 3–9 is described in Schemes 1 and 2. 
Scheme 1. Synthesis of acetylenic derivatives of betulin 3–6. 
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Treatment of betulin (1) with the corresponding chloroformate in benzene in the presence of 
pyridine at room temperature gave a mixture of mono- 3 and diesters 4, in which the first isomers 3 
were the major products due to the fact that reactivity of the hydroxyl group at C-28 is much higher 
than that of the C-3 one. The mixtures were separated by column chromatography to afford pure 
products 3 and 4 in 54%–69% and 23%–28% yields, respectively. The reaction of betulin (1) with 
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propynoic acid or phenylpropynoic acid or propanoic acid in dichloromethane in the presence of 
catalytic amount of dicyclohexylcarbodiimide (DCC) and 4-dimetylaminopyridine (DMAP) afforded 
mixtures of mono- 5 and diester 6, which were separated by column chromatography to give pure 5 
and 6 in 50%–86% and 11%–27% yields, respectively.  
Scheme 2. Synthesis of betulin derivatives 7 and 8. 
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For the synthesis of compounds 8 (Scheme 2) the corresponding monoacetylated substrate 7a was 
prepared, according to the method described in literature [28]. The synthesis of 28-O-acetylbetulin 
(7a) was achieved by selective acetylation of the primary hydroxyl group of betulin (1) with an 
equimolar amount of acetic anhydride in dichloromethane in the presence of DMAP and pyridine at 
room temperature. The reaction also gave small amount of 3,28-O,O'-diacetylbetulin (7b) which was 
separated by column chromatography. 
The 28-O-acetylbetulin (7a) was then treated with corresponding chloroformates in benzene in the 
presence of pyridine under mild conditions to afford 28-O-acetyl-3-O'-alkynyloxycarbonylbetulins 8 in 
good yields (63%–89%). The structure of all new compounds 3–8 were determined on the basis of 
their 1H, 13C-NMR, IR and MS spectra, together with elemental analyses. In addition, crystal structure 
of 5a was determined by X-ray structural analysis. For the first time, crystal structure of an acetylenic 
derivative of betulin-DMSO solvate is reported here. 
2.2. Crystal Structure 
Crystals of 28-O-propynoylbetulin (5a) for X-ray structural analysis were grown from a DMSO 
solution as a 28-O-propynoylbetulin-DMSO solvate of 1:1 stoichiometry. The crystal structure of 5a is 
shown in Figure 2. The compound crystallizes in the hexagonal system (space group P65) with  
a = 2.6511 (1) nm, b = 2.6511 (1) nm, c = 8.3895 (2) nm, α = 90°, β = 90°, γ = 120°, V = 510.6 (1) nm3, 
Z = 6. The six-membered rings have a chair conformation, while the cyclopentane ring adopts a twisted 
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conformation. All ring junctions in the 28-O-propynoylbetulin-DMSO solvate are trans-fused. A 
similar ring conformation was also observed in betulin-DMSO solvate [6], 3,28-O,O'-diacetylbetulin [29] 
and betulinic acid-DMSO solvate [30]. 
Figure 2. Molecular structure with atomic numbering scheme of 28-O-propynoylbetulin – 
DMSO solvate 5a with displacement ellipsoids of 50% probability. 
 
The methyl groups at carbon atoms C-24, C-25, C-26, C-27 occupy the axial positions, whereas the 
methyl group at C-23 and the isopropenyl group at C-19 are equatorial. The torsion angle  
C29-C20-C19-C21 describing the orientation of the isopropenyl group is equal to 105.4°. This 
conformation is very similar to that observed for the corresponding angles in 3,28-O,O'-diacetylbetulin 
(107.18°) [29] and in betulin-ethanol solvate (88.6°) [5] but differs from that observed for the structure 
of betulin-DMSO solvate (−96.8°) [6], and for betulinic acid-DMSO solvate (−112.2°) [30].  
The OH group at C-3 is an equatorial orientation, while the substituted hydroxymethyl group is 
attached to the atom C-17 in an axial orientation. The oxygen atom O-4 of DMSO and the hydroxyl 
group at C-3 of betulin (1) are involved in the O1 – H1…O4 bond, which is relatively strong with 
short H…O distance (1.86 Å) and almost linear directionality (169.4°).  
2.3. Cytotoxic Activity 
Cytotoxic activities of all newly synthesized compounds including betulin (1) were tested in SRB or 
MTT (in the case of leukemia cells) assay for their antiproliferative activity in vitro against three 
human cancer cell lines: SW707 (colorectal adenocarcinoma), CCRF/CEM (leukemia), T47D (breast 
cancer), and murine leukemia P388 as well as Balb3T3 normal fibroblasts cell lines. The results of the 
cytotoxic activity in vitro were expressed as an IC50 value (μg/mL), i.e., the concentration of 
compound which inhibits the proliferation of 50% of tumor cells as compared to the control untreated 
cells. Cisplatin was used as a reference cytotoxic agent (positive test control). A value of less than  
4 μg/mL was considered as an antiproliferative activity criterion for synthetic compounds [31]. The 
results of the cytotoxicity studies are summarized in Table 1. 
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Table 1. Cytotoxic activity of betulin (1), acetylenic betulins 3–8 and cisplatin reference 
compound against the cells of the tested human and murine cancer cell lines. 
Compd. 
Cytotoxic activity IC50 [µg/mL] 
Human Murine 
 R1 R2 T47D CCRF/CEM SW707 P388 Balb3T3 
1 - - 32.4 ± 10.7 10.9 ± 5.5 22.9 ± 15.4 5.5 ± 3.3 47.3 ± 7.9 
3a CH2C CH  - 7.2 ± 1.7 3.2 ± 0.4 9.2 ± 7.1 2.9 ± 0.2 3.9 ± 2.8 
3b CH2CH2C CH - 6.9 ± 2.3 5.2 ± 1.4 22.6 ± 11.9 3.6 ± 1.3 19.5 ± 13.9
3c CH2C CCH3  - 20.1 ± 5.3 6.8 ± 2.9 36.9 ± 6.3 5.5 ± 2.8 28.4 ± 17.6
3d CH2CH3  - 6.6 ± 1.3 4.1 ± 0.2 20.8 ± 14.7 3.8 ± 1.9 19.1 ± 13.5
4a CH2C CH  - Neg Neg Neg 33.4 ± 1.7 Neg 
4b CH2CH2C CH  - Neg Neg Neg Neg Neg 
4c CH2C CCH3  - Neg Neg Neg 50.4 ± 31.1 Neg 
4d CH2CH3  - 69.1 ± 12.4 52.6 ± 8.3 Neg 46.8 ± 21.6 Neg 
5a - C CH  9.1 ± 1.9 0.02 ± 0.001 14.9 ± 3.3 0.4 ± 0.1 0.3 ± 0.05 
5b - C CPh  Neg 49.0 ± 9.8 Neg Neg Neg 
5c -  CH2CH3  12.1 ± 4.4 8.1 ± 0.9 29.2 ± 24.4 3.3 ± 0.8 32.3 ± 23.0
6a - C CH  16.2 ± 4.3 9.9 ± 7.0 9.5 ± 1.9 31.9 ± 1.4 21.1 ± 2.6 
6b - C CPh  Neg 66.0 ± 2.8 Neg Neg Neg 
6c - CH2CH3  26.6 ± 6.8 Neg 42.3 ± 9.4 68.1 ± 14.8 Neg 
7a - - 4.9 ± 0.6 3.4 ± 0.3 5.1 ± 2.5 12.5 ± 14.7 29.7 ± 35.8
7b - - Neg 34.1 ± 6.4 Neg 40.2 ± 5.0 Neg 
8a CH2C CH  - Neg Neg Neg Neg Neg 
8b CH2C CCH3  - Neg Neg Neg 46.7 ± 16.2 Neg 
8c CH2CH2C CH  - Neg Neg Neg Neg Neg 
8d CH2CH3  - Neg Neg Neg Neg Neg 
Cisplatin   3.1 ± 1.0 2.0 ± 0.5 2.2 ± 0.5 0.5 ± 0.3 2.7 ± 0.3 
Neg – negative in the concentration used. 
As shown in Table 1, betulin (1) exhibited notably lower anticancer activity against the investigated 
cancer cell lines, with IC50 values in the 10.9–47.3 μg/mL range, except for leukemia P388 cell line 
(IC50 = 5.5 μg/mL). In this case, the selectivity index (SI) value, expressed as the ratio of IC50 of 
normal fibroblast/ IC50 on corresponding cancer cell line, is equal to 8.6. The introduction of an 
acetylenic formate group at the C-28 led to an increase of activity against the tested human and murine 
cancer lines. In the series of derivatives 3, the most active compound 3a was three to four times more 
cytotoxic than betulin (1) against cancer cells applied. Moreover, the degree of selectivity of this 
compound was lower than that of betulin (1) and derivatives 3b–d. By comparing the cytotoxic 
activities of monoesters 3a–c, it was found that the cytotoxic potency may be dependent on the length 
of the alkynyl chain and position of the triple bond on the formate group at the C-28 of betulin 
derivatives 3. The compound, having a shorter alkynyl chain, was found to be more cytotoxic to the 
cancer cell lines. A terminal triple bond seems to be necessary for a good activity. The cytotoxic 
activity of compound 3d is similar to that of 3b and it is lower than that observed for 3a. This indicates 
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that ethyl formate and 3-butynyl formate substituents at position 28 had a similar effect on the 
antiproliferative activity of these compounds. The structure-activity relationships indicated that the 
rank order of the cytotoxic activity observed in monoesters 3, according to the nature of the formate 
substituent is as follows: propargyl > 3-butynyl = ethyl > 2-butynyl. The introduction of a second 
formate group at the C-3 position in monoesters 3 led to the complete loss of the activity (compounds 4). 
Replacement of the hydroxyl group at C-28 position in betulin (1) by a propynoyloxy function, i.e., 
monoester 5a, resulted in increase of activity, especially against the cells of CCRF/CEM, with IC50 
value of 0.02 μg/mL. It is interesting to note that compound 5a was 545 times more cytotoxic than 
betulin (1) and 100 times more cytotoxic than cisplatin against CCRF/CEM leukemia cells. It was also 
observed that 5a was more selective (SI = 15) towards CCRF/CEM than betulin (1). These results 
suggest that the propynoyloxy function is important for anti-leukemia activity. On the other hand, 
addition of a second propynoyl group at C-3 in monoester 5a led to a decrease of activity except for 
the activity against the SW707 colon cancer cell (compound 6a).  
Though the exact reasons for this influence of propynoyl group are not quite well understood, we 
assume that the cytotoxic activity of compound 5a may be a consequence of the higher electrophilicity 
of its triple bond. We suggest that due to the strong negative effect of the carbonyl group, the 
mesomeric formula describing such a delocalization of the electron density of the triple bond has a 
cumulene structure 5-A and carbene structure 5-B (Figure 3) and it can interact very easily with 
nucleophilic reactive groups in living systems such as amines or thiols. In order to understand the 
effect of the triple bond of the propynoyl pharmacophore, derivative 5c was tested. It is interesting to 
note that replacement of the ethynyl group (compound 5a) by the ethyl group (compound 5c) resulted 
in a decrease of activity, especially against leukemia (CCRF/CEM and P388) cell lines. These results 
suggested that the triple bond directly bonded to carbonyl group of the substituent at the C-28 position 
seem to be essential for anticancer activity. This finding is in a good agreement with results from Csuk 
and co-workers showing that the 28-etynylbetulin and its carbonyl derivatives exhibited a higher 
cytotoxic activity compared to betulinic acid [23]. It was also reported that several acetylenic natural 
products possessing fungicidal properties have a conjugation of the triple bond to an adjacent carbonyl 
function [32]. However, the mono- 5b and diester 6b containing phenylproynoyl groups are inactive. 
The structure-activity relationships observed in compounds 5 indicated that the rank order of the 
cytotoxic activity, against all cancer cell lines applied, according to the nature of the acyloxy 
substituent, is as follows: propynoyl > propanoyl > phenylpropynoyl. It indicates that the betulins 
where the carbonyl group (at C-28 position) is directly bonded to triple bond of the ethynyl substituent, 
show a strong cytotoxic effect especially against human leukemia (CCRF/CEM) cancer cells with SI 
value equal to 15 and higher than betulin (1).  
The 28-O-acetylbetulin 7a showed a higher activity than the parent compound 1. But the 
introduction of the acetyl group at position C-3 in the compound 7a significantly decreased the 
cytotoxicity (compound 7b) in all the tested cell lines when compared to betulin (1) and 7a. These 
results are consistent with the reported data for the anticancer activity in vitro of acetyl derivatives of 
betulin [33]. On the other hand, esterification of the hydroxyl group at the C-3 of 28-O-acetylbetulin 
(7a) with acetylenic chloroformates led to the total inactive compounds 8. The obtained results also 
suggest that the free C-3 hydroxyl function group is important for the cytotoxicity of studied compounds. 
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Figure 3. Proposed mesomeric structures of propynoyl pharmacophore of 28-O-
propynoylbetulin (5a).  
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3. Experimental 
3.1. General Techniques 
Melting points were determined in open capillary tubes on a Boetius melting point apparatus and 
are uncorrected. NMR spectra (600/150 MHz) were recorded on a Bruker MSL 600 spectrometer in 
CDCl3 solvents with tetramethylsilane as internal standard; chemical shifts are reported in ppm () and 
J values in Hz. Multiplicity is designated as singlet (s), doublet (d), triplet (t), quartet (q), multiplet 
(m). Mass spectra were recorded under EI conditions on a Finnigan MAT 95 instrument, IR spectra 
(KBr, pellet) on a IRAffinity-1 Shimadzu spectrophotometer. Elemental C, H analyses were obtained 
on a Carlo Erba Model 1108 analyzer. TLC was performed on silica gel 60 254F plates (Merck, 
Darmstadt, Germany) using a mixture of chloroform and ethanol (20:1 or 40:1, v/v) as an eluent. Spots 
were visualized by spraying with solution of 5% sulfuric acid, followed by heating. Column 
chromatography was performed on silica gel 60, <63 μm (Merck) using a mixture of chloroform and 
ethanol (40:1, v/v) as an eluent. Solvents were dried and purified according to usual procedures. 
3.2. Isolation of Betulin (1) 
External bark (100 g) of the white birch (Betula verrucosa), collected in Poland, was soaked in 
dichloromethane (1 L) and refluxed for 8 hours. The solvent was removed under reduced pressure and 
the crude product was purified by column chromatography (chloroform/ethanol, 20:1, v/v) to give 1 as 
a white solid (19 g, 19%): m.p. 250–252 °C (lit. m.p. 252–253 °C [6]; 255–256 °C [27]); Rf 0.42 
(chloroform/ethanol, 20:1, v/v). The 1H- and 13C-NMR spectral data of 1 were in agreement with those 
published in the literature [6]. 
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3.3. General Procedure for the Synthesis of Monoesters 3 and Diesters 4 
To a mixture of betulin (1, 0.44 g, 1 mmol) and pyridine (2.5 mL) in dry benzene (6 mL) at 0–5 °C, a 
solution of propargyl chloroformate or 2-butyn-1-yl chloroformate or 3-butyn-1-yl chloroformate or 
ethyl chloroformate (3.0 mmol) in dry benzene (5 mL) was added. Stirring at this temperature was 
continued for 4 h. Then the reaction mixture was allowed to warm to room temperature and stirred 
over night. At the end of the reaction 5 mL of chloroform was added and the reaction mixture was 
washed with 1 N sulfuric acid, followed by water, then dried with anhydrous magnesium sulfate and 
concentrated under reduced pressure. The crude product was purified by column chromatography 
(chloroform/ethanol, 40:1, v/v) to give pure corresponding monoesters 3 and diesters 4. 
28-O-Propargyloxycarbonylbetulin (3a). Yield: 69%, m.p. 190–193 °C, Rf 0.49 (chloroform/ethanol, 
40:1, v/v); 1H-NMR (CDCl3) : 0.76 (s, 3H, CH3), 0.82 (s, 3H, CH3), 0.97 (s, 3H, CH3), 0.98 (s, 3H, 
CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.06–2.01 (m, 25H, CH, CH2), 2.42 (m, 1H, H-19), 2.53 (t, 
J = 2.4 Hz, 1H, C≡CH), 3.18 (m, 1H, H-3), 3.95 (d, J = 10.8 Hz, 1H, H-28), 4.38 (d, J = 10.8 Hz, 1H, 
H-28), 4.59 (s, 1H, H-29), 4.69 (s, 1H, H-29), 4.74 (d, J = 2.4 Hz, 2H, OCH2). 13C-NMR (CDCl3) : 
14.9, 15.3, 15.4, 15.9, 16.2, 18.3, 19.1, 20.8, 25.2, 26.9, 27.4, 27.9, 28.0, 29.5, 34.2, 34.3, 37.1, 37.6, 
38.7, 38.8. 40.8, 42.7, 46.5, 47.6, 48.8, 50.3, 55.2, 55.4, 67.3, 75.6, 78.9, 109.9, 149.9, 155.1. IR (KBr, 
cm−1) ν: 3421, 3309, 2132, 1749, 1250, 885. EI MS (70 eV) m/z (rel. intensity): 524 (M+, 11), 411 
(45), 207 (59), 203 (58), 189 (100), 135 (58); Elemental anal. (%), calcd. for C34H52O4: C, 77.82; H, 
9.99; found: C, 77.59; H, 9.84. 
28-O-(3-Butynyloxycarbonyl)betulin (3b). Yield: 64%, m.p. 86–88 °C, Rf 0.45 (chloroform/ethanol, 
40:1, v/v); 1H-NMR (CDCl3) : 0.76 (s, 3H, CH3), 0.82 (s, 3H, CH3), 0.97 (s, 3H, CH3), 0.98 (s, 3H, 
CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.05–2.02 (m, 25H, CH, CH2), 2.03 (t, J = 2.7 Hz, 1H, C≡CH), 
2.43 (m, 1H, H-19), 2.59 (m, 2H, J = 2.7 Hz, J = 7.2 Hz, OCH2CH2), 3.19 (m, 1H, H-3), 3.93 (d,  
J = 10.8 Hz, 1H, H-28), 4.25 (t, J = 7.2 Hz, 2H, OCH2), 4.36 (d, J = 10.8 Hz, 1H, H-28), 4.59 (s, 1H, 
H-29), 4.69 (s, 1H, H-29). 13C-NMR (CDCl3) : 14.7, 15.3, 15.9, 16.1, 18.2, 19.0, 20.7, 25.1, 26.9, 
27.3, 27.9, 29.4, 34.1, 34.3, 37.1, 37.5, 38.6, 38.8, 40.8, 42.6, 46.5, 47.6, 48.7, 50.3, 55.2, 65.3, 66.7, 
70.2, 76.7, 78.9, 79.4, 109.9, 150.0, 155.4. IR (KBr, cm−1) ν: 3485, 3310, 2124, 1747, 1248, 884. EI 
MS (70 eV) m/z (rel. intensity): 538 (M+, 10), 207 (47), 203 (52), 189 (100), 135 (57); Elemental anal. 
(%), calcd. for C35H54O4: C, 78.02; H, 10.10; found: C, 78.32; H, 9.98. 
28-O-(2-Butynyloxycarbonyl)betulin (3c). Yield: 54%, m.p. 112–114 °C, Rf 0.48 (chloroform/ethanol, 
40:1, v/v); 1H-NMR (CDCl3) : 0.76 (s, 3H, CH3), 0.82 (s, 3H, CH3), 0.96 (s, 3H, CH3), 0.97 (s, 3H, 
CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.06–2.01 (m, 25H, CH, CH2), 1.87 (t, J = 2.4 Hz, 3H, 
C≡CCH3), 2.42 (m, 1H, H-19), 3.19 (m, 1H, H-3), 3.94 (d, J = 10.8 Hz, 1H, H-28), 4.37 (d, J = 10.8 Hz, 
1H, H-28), 4.59 (s, 1H, H-29), 4.69 (s, 1H, H-29), 4.70 (q, 2H, J = 2.4 Hz, OCH2). 13C-NMR (CDCl3) 
: 3.7, 14.7, 15.3, 15.9, 16.1, 18.2, 19.0, 20.7, 25.1, 26.9, 27.3, 27.9, 29.4, 29.4, 34.1, 34.3, 37.1, 37.5, 
38.6, 38.8, 40.8, 42.6, 46.5, 47.6, 48.7, 50.2, 55.2, 56.1, 66.9, 72.5, 76.7, 78.9, 109.9, 150.0, 155.2. IR 
(KBr, cm−1) ν: 3462, 2942, 2248, 1748, 1248, 883. EI MS (70 eV) m/z (rel. intensity): 538 (M+, 14), 
207 (48), 203 (53), 189 (100), 135 (60); Elemental anal. (%), calcd. for C35H54O4: C, 78.02; H, 10.10; 
found: C, 77.84; H, 10.22. 
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28-O-Ethoxycarbonylbetulin (3d). Yield: 68%, m.p. 94–96 °C, Rf 0.47 (chloroform/ethanol, 40:1, v/v); 
1H-NMR (CDCl3) : 0.75 (s, 3H, CH3), 0.81 (s, 3H, CH3), 0.96 (s, 3H, CH3), 0.97 (s, 3H, CH3), 1.03 
(s, 3H, CH3), 1.31 (t, J = 7.2 Hz, 3H, OCH2CH3), 1.67 (s, 3H, CH3), 1.05–2.02 (m, 25H, CH, CH2), 
2.42 (m, 1H, H-19), 3.18 (m, 1H, H-3), 3.90 (d, J = 10.8 Hz, 1H, H-28), 4.20 (q, J = 7.2 Hz, 2H, 
OCH2), 4.32 (d, J = 10.8 Hz, 1H, H-28), 4.58 (s, 1H, H-29), 4.68 (s, 1H, H-29). 13C-NMR (CDCl3) : 
14.2, 14.7, 15.3, 15.9, 16.0, 18.2, 19.0, 20.7, 25.1, 26.9, 27.3, 27.9, 29.5, 34.1, 34.3, 37.1, 37.5, 38.6, 
38.8, 40.8, 42.6, 46.4, 47.6, 48.7, 50.3, 55.2, 63.9. 66.3, 78.9, 109.8, 150.0, 155.7. IR (KBr, cm−1) ν: 
3486, 2942, 1744, 1249, 1013, 882. EI MS (70 eV) m/z (rel. intensity): 514 (M+, 18), 424 (40), 203 
(54), 189 (100), 135 (56); Elemental anal. (%), calcd. For C33H54O4: C, 77.00; H, 10.57; found: C, 
77.28; H, 10.43. 
3,28-O,O'-Di(propargyloxycarbonyl)betulin (4a). Yield: 27%, m.p. 125–127 °C, Rf 0.77 
(chloroform/ethanol, 40:1, v/v); 1H-NMR (CDCl3) : 0.84 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.91 (s, 3H, 
CH3), 0.96 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.67 (s, 3H, CH3), 1.07–2.02 (m, 25H, CH, CH2), 2.42 (m, 
1H, H-19), 2.51 (t, J = 2.4 Hz, 1H, C≡CH), 2.53 (t, J = 2.4 Hz, 1H, C≡CH), 3.94 (d, J = 10.8 Hz, 1H, 
H-28), 4.33 (m, 1H, H-3), 4.37 (d, J = 10.8 Hz, 1H, H-28), 4.59 (s, 1H, H-29), 4.68 (s, 1H, H-29), 4.73 
(d, J = 2.4 Hz, 2H, OCH2), 4.76 (d, J = 2.4, Hz, 2H, OCH2). 13C-NMR (CDCl3) : 15.9, 16.0, 16.1, 
16.2, 16.3, 18.0, 19.0, 20.7, 23.5, 25.1, 27.0, 27.7, 27.9, 29.4, 34.0, 34.3, 37.0, 37.6, 38.0, 38.3, 40.8, 
42.7, 46.5, 47.6, 48.7, 50.2, 54.9, 55.2, 55.6, 67.2, 75.6, 75.9, 77.0, 86.2, 109.9, 149.9, 153.9, 154.5. IR 
(KBr, cm−1) ν: 3305, 2941, 2133, 1730, 1442, 1253. EI MS (70 eV) m/z (rel. intensity): 606 ((M+, 7), 
506 (41), 203 (52), 189 (100), 121 (42); Elemental anal. (%), calcd. for C38H54O6: C, 75.21; H, 8.97; 
found: C, 75.03; H 9.12. 
3,28-O,O'-Di(3-butynyloxycarbonyl)betulin (4b). Yield: 23%, m.p. 140–142 °C, Rf 0.75 (chloroform/ 
ethanol, 40:1, v/v); 1H-NMR (CDCl3) : 0.84 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.91 (s, 3H, CH3), 0.97 
(s, 3H, CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.05–2.02 (m, 25H, CH, CH2), 2.01 (t, J = 2.4 Hz, 
1H, C≡CH), 2.03 (t, J = 2.4 Hz, 1H, C≡CH), 2.43 (m, 1H, H-19), 2.59 (m, 4H, 2 × OCH2CH2), 3.94 
(d, J = 10.8 Hz, 1H, H-28), 4.24 (m, 4H, 2 × OCH2), 4.31 (m, 1H, H-3), 4.36 (d, J = 10.8 Hz, 1H,  
H-28), 4.59 (s, 1H, H-29), 4.69 (s, 1H, H-29). 13C-NMR (CDCl3) : 14.6, 15.9, 16.1, 16.3, 18.0, 19.0, 
20.7, 23.5, 25.0, 26.9, 27.8, 29.4, 33.9, 34.3, 36.9, 37.5, 38.0, 38.2, 40.8, 42.6, 46.4, 47.6, 48.7, 50.1, 
55.3, 64.9, 65.3, 66.7, 70.1, 70.2, 76.7, 79.4, 79.5, 79.4, 85.6, 109.9, 149.9, 154.9, 155.4. IR (KBr, 
cm−1) ν: 3312, 2951, 2128, 1745, 1249, 884. EI MS (70 eV) m/z (rel. intensity): 634 (M+, 3), 203 (40), 
189 (100), 135 (48), 121 (46); Elemental anal. (%), calcd. for C40H58O6: C, 75.67; H, 9.21; found: C, 
75.89; H, 9.14. 
3,28-O,O'-Di(2-butynyloxycarbonyl)betulin (4c). Yield: 28%, m.p. 70–73 °C, Rf 0.78 (chloroform/ 
ethanol, 40:1, v/v); 1H-NMR (CDCl3) : 0.84 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.91 (s, 3H, CH3), 0.97 
(s, 3H, CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.05–2.02 (m, 25H, CH, CH2), 1.86 (t, J = 2.4 Hz, 
3H, C≡CCH3), 1.87 (t, J = 2.4 Hz, 3H, C≡CCH3), 2.42 (m, 1H, H-19), 3.94 (d, J = 10.8 Hz, 1H, H-28), 
4.32 (m, 1H, H-3), 4.37 (d, J = 10.8 Hz, 1H, H-28), 4.59 (s, 1H, H-29), 4.69 (s, 1H, H-29), 4.71 (m, 
4H, 2 × OCH2). 13C-NMR (CDCl3) : 5.1, 5.3, 15.9, 16.1, 16.3, 18.0, 19.0, 20.7, 23.5, 25.0, 26.9, 27.8, 
29.4, 33.9, 34.2, 36.9, 37.5, 37.9, 38.2, 40.8, 42.6, 46.4, 47.6, 48.7, 50.1, 55.3, 55.8, 56.1, 56.4, 66.9, 
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72.5, 72.7, 83.9, 84.1, 84.2, 85.8, 109.9, 149.9, 154.7, 155.2. IR (KBr, cm−1) ν: 2948, 2241, 1747, 
1456, 1265, 884. EI MS (70 eV) m/z (rel. intensity): 634 (M+, 6), 520 (94), 203 (42), 189 (100), 135 
(41); Elemental anal. (%), calcd. for C40H58O6: C, 75.67; H, 9.21; found: C, 75.42; H, 9.33. 
3,28-O,O'-Di(ethoxycarbonyl)betulin (4d). Yield: 24%, m.p. 84–86 °C, Rf 0.76 (chloroform/ethanol, 
40:1, v/v); 1H-NMR (CDCl3) : 0.86 (s, 3H, CH3), 0.87 (s, 3H, CH3), 0.93 (s, 3H, CH3), 0.99 (s, 3H, 
CH3), 1.05 (s, 3H, CH3), 1.32 (m, 6H, 2 × OCH2CH3), 1.69 (s, 3H, CH3), 0.81–2.05 (m, 25H, CH, 
CH2), 2.44 (m, 1H, H-19), 3.92 (d, J = 10.8 Hz, 1H, H-28), 4.22 (m, 4H, 2 × OCH2), 4.31 (m, 1H, H-3) 
4.35 (d, J = 10.8 Hz, 1H, H-28), 4.60 (s, 1H, H-29), 4.70 (s, 1H, H-29). 13C-NMR (CDCl3) : 14.2, 14.7, 
16.0, 16.1, 16.4, 18.1, 19.1, 20.8, 23.6, 25.1, 27.0, 27.8, 29.5, 34.1, 34.3, 37.0, 37.6, 38.0, 38.3, 40.9, 
42.7, 46.5, 47.6, 48.8, 50.2, 55.4, 63.6, 63.9, 66.4, 85.1, 109.9, 150.0, 155.2, 155.7. IR (KBr, cm−1) ν: 
2948, 1741, 1466, 1265, 1009, 885. EI MS (70 eV) m/z (rel. intensity): 586 (M+, 4), 496 (70), 203 (42), 
189 (100), 135 (41). Elemental anal. (%), calcd. for C36H58O6: C, 73.68; H, 9.96; found: C, 73.56; H, 9.85. 
3.4. General Procedure for the Synthesis of Monoesters 5 and Diesters 6 
To a mixture of betulin (1, 0.44 g, 1 mmol) and propynoic acid (0.08 g, 1.10 mmol), phenylpropynoic 
acid (0.16 g, 1.10 mmol) or propanoic acid (0.08 g, 1.10 mmol) in dry dichloromethane (5 mL) under 
argon at −10 °C, a solution of DCC (0.23 g, 1.12 mmol) and DMAP (0.01 g, 0.08 mmol) in dry 
dichloromethane (1 mL) was added. Stirring at this temperature was continued for 5 h. Then the 
reaction mixture was allowed to warm to room temperature and stirred over night. After the reaction 
was complete, the reaction mixture was filtered and the solvent was removed under reduced pressure. 
The crude product was purified by column chromatography (chloroform/ethanol 40:1, v/v) to give pure 
corresponding monoesters 5 and diesters 6. 
28-O-Propynoylbetulin (5a). Yield: 60%, m.p. 133–135 °C, Rf 0.46 (chloroform/ethanol, 20:1, v/v); 
1H-NMR (CDCl3) : 0.76 (s, 3H, CH3), 0.82 (s, 3H, CH3), 0.97 (s, 3H, CH3), 0.98 (s, 3H, CH3), 1.03 
(s, 3H, CH3), 1.68 (s, 3H, CH3), 1.06–1.98 (m, 25H, CH, CH2), 2.43 (m, 1H, H-19), 2.89 (s, 1H, 
C≡CH), 3.18 (m, 1H, H-3), 3.99 (d, J = 10.8 Hz, 1H, H-28), 4.38 (d, J = 10.8 Hz, 1H, H-28), 4.59 (s, 
1H, H-29), 4.69 (s, 1H, H-29). 13C-NMR (CDCl3) : 14.7, 15.3, 15.9, 16.0, 18.2, 19.1, 20.7, 25.1, 26.9, 
27.3, 27.9, 29.4, 29.5, 34.1, 34.4, 37.1, 37.6, 38.6, 38.8, 40.8, 42.6, 46.3, 47.6, 48.7, 50.3, 55.2, 64.8, 
74.6, 74.6, 78.9, 109.9, 149.8, 153.2. IR (KBr, cm−1) ν: 3419, 3302, 2994, 2120, 1715, 1227. EI MS 
(70 eV) m/z (rel. intensity): 494 (M+, 32), 207 (66), 203 (50), 189 (100), 135 (59); Elemental anal. (%), 
calcd. for C33H50O3: C, 80.11; H, 10.19; found: C, 80.39; H, 10.02. 
28-O-Phenylpropynoylbetulin (5b). Yield: 70%, m.p. 204–206 °C, Rf 0.47 (chloroform/ethanol, 20:1, 
v/v); 1H-NMR (CDCl3) : 0.76 (s, 3H, CH3), 0.83 (s, 3H, CH3), 0.97 (s, 3H, CH3), 0.99 (s, 3H, CH3), 
1.05 (s, 3H, CH3), 1.69 (s, 3H, CH3), 1.07–2.05 (m, 25H, CH, CH2), 2.46 (m, 1H, H-19), 3.18 (m, 1H, 
H-3), 4.04 (d, J = 10.8 Hz, 1H, H-28), 4.42 (d, J = 10.8 Hz, 1H, H-28), 4.60 (s, 1H, H-29), 4.70 (s, 1H, 
H-29), 7.36–7.60 (m, 5H, Ar-H). 13C-NMR (CDCl3) : 14.7, 15.3, 16.0, 16.1, 18.2, 19.1, 20.7, 25.1, 
27.0, 27.3, 27.9, 29.5, 29.6, 34.1, 34.5, 37.1, 37.6, 38.6, 38.8, 40.8, 42.7, 46.4, 47.6, 48.8, 50.3, 55.2, 
64.5, 78.9, 80.7, 86.2, 109.9, 119.6, 128.5, 128.5, 130.5, 132.9, 132.9, 149.9, 154.7. IR (KBr, cm−1) ν: 
3587, 2993, 2220, 1691, 1287, 1195. EI MS (70 eV) m/z (rel. intensity): 570 (M+, 15), 189 (71), 135 
Molecules 2013, 18 4537 
 
(42), 129 (100), 95 (41); Elemental anal. (%), calcd. for C39H54O3: C, 82.06; H, 9.53; found: C, 82.31; 
H, 9.48. 
28-O-Propanoylbetulin (5c). Yield: 86%, m.p. 160–162 °C, Rf 0.46 (chloroform/ethanol, 20:1, v/v); 
1H-NMR (CDCl3) : 0.75 (s, 3H, CH3), 0.81 (s, 3H, CH3), 0.96 (s, 3H, CH3), 0.97 (s, 3H, CH3), 1.02 
(s, 3H, CH3), 1.15 (t, J = 7.2 Hz, 3H, CH2CH3), 1.67 (s, 3H, CH3), 0.88–1.93 (m, 25H, CH, CH2), 2.34 
(q, J = 7.2 Hz, 2H, CH2CH3), 2.43 (m, 1H, H-19), 3.18 (m, 1H, H-3), 3.84 (d, J = 10.8 Hz, 1H, H-28), 
4.25 (d, J = 10.8 Hz, 1H, H-28), 4.58 (s, 1H, H-29), 4.68 (s, 1H, H-29). 13C-NMR (CDCl3) : 9.2, 14.7, 
15.3, 15.9, 16.0, 18.2, 19.1, 20.7, 25.1, 27.0, 27.3, 27.7, 27.9, 29.5, 29.7, 34.1, 34.5, 37.1, 37.5, 38.6, 
38.8, 40.8, 42.6, 46.3, 47.6, 48.7, 50.3, 55.2, 62.5, 78.9, 109.8, 150.1, 174.9. IR (KBr, cm−1) ν: 3357, 
2940, 1735, 1276, 1186, 882. EI MS (70 eV) m/z (rel. intensity): 498 (M+, 17), 207 (52), 203 (54), 189 
(100), 135 (58); Elemental anal. (%), calcd. for C33H54O3: C, 79.46; H, 10.91; found: C, 79.34; H, 10.82. 
3,28-O,O'-Dipropynoylbetulin (6a). Yield: 12%, m.p. 102–104 °C, Rf 0.73 (chloroform/ethanol, 20:1, 
v/v); 1H-NMR (CDCl3) : 0.86 (s, 3H, CH3), 0.87 (s, 3H, CH3), 0.89 (s, 3H, CH3), 0.98 (s, 3H, CH3), 
1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.07–2.01 (m, 25H, CH, CH2), 2.43 (m, 1H, H-19), 2.85 (s, 1H, 
C≡CH), 2.89 (s, 1H, C≡CH), 3.99 (d, J = 10.8 Hz, 1H, H-28), 4.39 (d, J = 10.8 Hz, 1H, H-28), 4.59 
(m, 1H, H-3), 4.60 (s, 1H, H-29), 4.69 (s, 1H, H-29). 13C-NMR (CDCl3) : 14.7, 15.9, 16.1, 16.4, 18.1, 
19.1, 20.7, 23.4, 25.1, 26.9, 27.8, 29.4, 29.5, 34.0, 34.4, 37.0, 37.6, 37.9, 38.3, 40.8, 42.6, 46.3, 47.6, 
48.7, 50.2, 55.3, 64.8, 74.1, 74.6, 74.7, 75.1, 83.6, 110.0, 149.8, 152.7, 153.2. IR (KBr, cm−1) ν: 3301, 
2945, 2119, 1714, 1234, 886. EI MS (70 eV) m/z (rel. intensity): 546 (M+, 9), 195 (46), 189 (53), 113 
(41), 55 (100); Elemental anal. (%), calcd. for C36H50O4: C, 79.08; H, 9.22; found: C, 79.16; H, 9.28. 
3,28-O,O'-Di(phenylpropynoyl)betulin (6b). Yield: 27%, m.p. 91–92 °C, Rf 0.79 (chloroform/ethanol, 
20:1, v/v); 1H-NMR (CDCl3) : 0.88 (s, 3H, CH3), 0.92 (s, 3H, CH3), 0.93 (s, 3H, CH3), 0.99 (s, 3H, 
CH3), 1.06 (s, 3H, CH3), 1.70 (s, 3H, CH3), 1.06–2.05 (m, 25H, CH, CH2), 2.46 (m, 1H, H-19), 4.04 
(d, J = 10.8 Hz, 1H, H-28), 4.42 (d, J = 10.8 Hz, 1H, H-28), 4.61 (s, 1H, H-29), 4.66 (m, 1H, H-3), 
4.71 (s, 1H, H-29), 7.36–7.60 (m, 10H, 2 × Ar-H). 13C-NMR (CDCl3) : 14.7, 16.0, 16.1, 16.5, 18.1, 
19.1, 20.8, 23.6, 25.1, 25.8, 25.9, 27.0, 27.9, 29.4, 29.5, 29.6, 34.1, 34.5, 37.0, 37.6, 38.0, 38.4, 40.9, 
42.7, 46.4, 47.6, 48.8, 50.2, 55.4, 64.5, 80.7, 81.0, 83.2, 85.7, 86.3, 109.9, 119.6, 119.8, 128.4, 128.5, 
130.4, 130.5, 132.9, 132.9, 149.9, 154.2, 154.7. IR (KBr, cm−1) ν: 2945, 2223, 1706, 1490, 1285, 1187. 
EI MS (70 eV) m/z (rel. intensity): 698 (M+, 6), 552 (30), 189 (33), 135 (15), 129 (100); Elemental 
anal. (%), calcd. for C48H58O4: C, 82.48; H, 8.36; found: C, 82.35; H, 8.27. 
3,28-O,O'-Dipropanoylbetulin (6c). Yield: 11%, m.p. 142–144 °C, Rf 0.71 (chloroform/ethanol, 20:1, 
v/v); 1H-NMR (CDCl3) : 0.83 (s, 3H, CH3), 0.83 (s, 3H, CH3), 0.84 (s, 3H, CH3), 0.96 (s, 3H, CH3), 
1.02 (s, 3H, CH3), 1.15 (m, 6H, 2 × CH2CH3), 1.68 (s, 3H, CH3), 1.06–1.96 (m, 25H, CH, CH2), 2.34 
(m, 4H, 2 × CH2CH3), 2.43 (m, 1H, H-19), 3.83 (d, J = 10.8 Hz, 1H, H-28), 4.26 (d, J = 10.8 Hz, 1H, 
H-28), 4.65 (m, 1H, H-3), 4.58 (s, 1H, H-29), 4.68 (s, 1H, H-29). 13C-NMR (CDCl3) : 9.2, 9.3, 14.7, 
15.9, 16.1, 16.5, 18.1, 19.1, 20.7, 23.6, 25.1, 27.0, 27.7, 27.9, 28.0, 29.5, 29.7, 34.0, 34.5, 37.0, 37.4, 
37.8, 38.3, 40.8, 42.6, 46.3, 47.6, 48.7, 50.2, 55.3, 62.5, 80.5, 109.8, 150.1, 174.3, 174.9. IR  
(KBr, cm−1) ν: 2960, 1736, 1461, 1261, 1185, 891. EI MS (70 eV) m/z (rel. intensity): 554 (M+, 7), 480 
Molecules 2013, 18 4538 
 
(100), 203 (45), 189 (98), 135 (37); Elemental anal. (%), calcd. for C36H58O4: C, 77.93; H, 10.54; 
found: C, 77.85; H, 10.62. 
3.5. Synthesis of 28-O-Acetylbetulin (7a) and 3,28-O,O'-Diacetylbetulin (7b) 
To a mixture of betulin (1, 1.0 g, 2.26 mmol), DMAP (0.01 g, 0.07 mmol) and pyridine (1.5 mL) in 
dry dichloromethane (9 mL) was added dropwise acetic anhydride (0.24 g, 2.26 mmol) at 0 °C, and the 
reaction mixture was stirred at room temperature. After being stirred for 18 h, the mixture was washed 
with 10% aqueous hydrochloric acid (30 mL), water (15 mL), saturated aqueous NaHCO3 solution and 
then brine (20 mL). After separation of phases, the organic layer was dried with anhydrous magnesium 
sulfate and concentrated under reduced pressure. The crude product was purified by column 
chromatography (chloroform/ethanol, 40:1, v/v) to give 28-O-acetylbetulin (7a, 0.77 g, 71%): m.p. 
214–215 °C (lit. m.p. 210–212 °C [28]; 217–219 °C [34]); Rf 0.44 (chloroform/ethanol, 20:1, v/v) and 
3,28-O,O'-diacetylbetulin (7b, 0.21 g, 18%): m.p. 220–222 °C (lit. m.p. 221–223 °C [34]). 1H and  
13C-NMR spectral data of 7a and 7b were in agreement with those published in the literature [28,34]. 
3.6. Synthesis of 28-O-acetyl-3-O'-alkynyloxycarbonylbetulins (8)  
To a mixture of 28-O-acetylbetulin (7a, 0.48 g, 1 mmol) and pyridine (2.5 mL) in dry benzene (6 mL) 
at 0–5 °C, a solution of propargyl chloroformate or 2-butyn-1-yl chloroformate or 3-butyn-1-yl 
chloroformate or ethyl chloroformate (2.0 mmol) in dry benzene (5 mL) was added. Stirring at this 
temperature was continued for 4 h. Then the reaction mixture was allowed to warm to room 
temperature and stirred over night. At the end of the reaction 5 mL of chloroform was added and the 
reaction mixture was washed with 1 N sulfuric acid, followed by water, then dried with anhydrous 
magnesium sulfate and concentrated under reduced pressure. The crude product was purified by 
column chromatography using chloroform/ethanol (40:1, v/v) to give pure corresponding esters 8. 
28-O-Acetyl-3-O'-propargyloxycarbonylbetulin (8a). Yield: 89%, m.p. 188–189 °C, Rf 0.73 (chloroform/ 
ethanol, 20:1, v/v); 1H-NMR (CDCl3) : 0.84 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.92 (s, 3H, CH3), 0.97 
(s, 3H, CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.06–1.99 (m, 25H, CH, CH2), 2.07 (s, 3H, 
COCH3), 2.44 (m, 1H, H-19), 2.51 (t, 1H, J = 2.4 Hz, C≡CH), 3.85 (d, J = 10.8 Hz, 1H, H-28), 4.24 
(d, J = 10.8 Hz, 1H, H-28), 4.33 (m, 1H, H-3), 4.58 (s, 1H, H-29), 4.68 (s, 1H, H-29), 4.71 (d, 2H,  
J = 2.4 Hz, OCH2). 13C-NMR (CDCl3) : 14.6, 16.0, 16.1, 18.1, 19.1, 20.8, 21.0, 23.5, 25.1, 27.0, 27.7, 
27.8, 29.5, 29.7, 34.1, 34.5, 37.0, 37.5, 38.0, 40.8, 42.6, 46.3, 47.7, 48.7, 50.2, 54.9, 55.6, 62.7, 75.4, 
75.9, 77.2, 86.2, 109.8, 150.1, 154.5, 171.6. IR (KBr, cm−1) ν: 3298, 2997, 2140, 1735, 1243, 889. EI 
MS (70 eV) m/z (rel. intensity): 566 (M+, 7), 466 (76), 203 (46), 189 (100), 135 (40); Elemental anal. 
(%), calcd. for C36H54O5: C, 76.28; H, 9.60; found: C, 76.49; H, 9.52. 
28-O-Acetyl-3-O'-(3-butynyloxycarbonyl)betulin (8b). Yield: 63%, m.p. 118–121 °C, Rf 0.72 
(chloroform/ethanol, 20:1, v/v); 1H-NMR (CDCl3) : 0.83 (s, 3H, CH3), 0.84 (s, 3H, CH3), 0.90 (s, 3H, 
CH3), 0.96 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.67 (s, 3H, CH3), 1.06–1.99 (m, 25H, CH, CH2), 2.00 (t,  
J = 2.7 Hz, 1H, C≡CH), 2.06 (s, 3H, COCH3), 2.44 (m, 1H, H-19), 2.57 (m, J = 2.7 Hz, J = 7.2 Hz 2H, 
OCH2CH2), 3.84 (d, J = 10.8 Hz, 1H, H-28), 4.21 (t, J = 7.2 Hz, 2H, OCH2), 4.25 (d, J = 10.8 Hz, 1H, 
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H-28), 4.32 (m, 1H, H-3), 4.58 (s, 1H, H-29), 4.68 (s, 1H, H-29). 13C-NMR (CDCl3) : 14.7, 15.9, 
16.1, 16.3, 18.0, 19.0, 20.7, 21.0, 23.5, 25.0, 26.9, 27.8, 29.5, 29.6, 34.0, 34.5, 36.9, 37.4, 38.0, 38.2, 
40.8, 42.6, 46.2, 47.6, 48.7, 50.2, 55.3, 62.7, 65.0, 65.5, 70.1, 79.4, 85.6, 109.8, 150.1, 154.9, 171.6. IR 
(KBr, cm−1) ν: 3284, 2944, 2212, 1741, 1249, 889. EI MS (70 eV) m/z (rel. intensity): 580 (M+, 7), 466 
(66), 203 (42), 189 (100), 135 (46); Elemental anal. (%), calcd. for C37H56O5: C, 76.51; H, 9.72; found: 
C, 76.79; H, 9.59. 
28-O-Acetyl-3-O'-(2-butynyloxycarbonyl)betulin (8c). Yield: 67%, m.p. 126–129 °C, Rf 0.75 
(chloroform/ethanol, 20:1, v/v); 1H-NMR (CDCl3) : 0.84 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.91 (s, 3H, 
CH3), 0.97 (s, 3H, CH3), 1.03 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.06–1.99 (m, 25H, CH, CH2), 1.86 (t,  
J = 2.4 Hz, 3H, C≡CCH3), 2.07 (s, 3H, COCH3), 2.44 (m, 1H, H-19), 3.84 (d, J = 10.8 Hz, 1H, H-28), 
4.24 (d, J = 10.8 Hz, 1H, H-28), 4.32 (m, 1H, H-3), 4.59 (s, 1H, H-29), 4.68 (s, 1H, H-29), 4.71 (q,  
J = 2.4 Hz, 2H, OCH2). 13C-NMR (CDCl3) : 3.6, 14.7, 16.1, 16.3, 18.0, 19.0, 20.7, 21.0, 23.5, 25.0, 
26.9, 27.8, 29.5, 29.6, 34.0, 34.5, 36.9, 37.4, 38.0, 38.2, 40.8, 42.6, 46.2, 47.6, 48.7, 50.2, 55.3, 56.4, 
62.7, 72.7, 83.8, 84.2, 85.9, 109.8, 150.1, 154.7, 171.6. IR (KBr, cm−1) ν: 2956, 2233, 1742, 1457, 
1256, 920. EI MS (70 eV) m/z (rel. intensity): 580 (M+, 3), 466 (64), 203 (37), 189 (100), 187 (47), 135 
(40); Elemental anal. (%), calcd. for C37H56O5: C, 76.51; H, 9.72; found: C, 76.63; H, 9.87. 
28-O-Acetyl-3-O'-(ethoxycarbonyl)betulin (8d). Yield: 84%, m.p. 200–202 °C, Rf 0.73 (chloroform/ 
ethanol, 20:1, v/v); 1H-NMR (CDCl3) : 0.84 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.91 (s, 3H, CH3), 0.97 
(s, 3H, CH3), 1.03 (s, 3H, CH3), 1.30 (t, J = 7.2 Hz, 3H, CH2CH3), 1.68 (s, 3H, CH3), 1.05–2.00 (m, 
25H, CH, CH2), 2.07 (s, 3H, COCH3), 2.44 (m, 1H, H-19), 3.85 (d, J = 10.8 Hz, 1H, H-28), 4.18 (q,  
J = 7.2 Hz, 2H, OCH2), 4.24 (d, J = 10.8 Hz, 1H, H-28), 4.30 (m, 1H, H-3), 4.59 (s, 1H, H-29), 4.69 (s, 
1H, H-29). 13C-NMR (CDCl3) : 14.3, 14.7, 16.0, 16.1, 16.4, 18.1, 19.1, 20.8, 21.0, 23.6, 25.1, 27.0, 
27.8, 29.6, 34.1, 34.5, 37.0, 37.5, 38.0, 38.3, 40.9, 42.7, 46.3, 47.7, 48.7, 50.2, 55.4, 62.8, 63.6, 85.1, 
109.8, 150.1, 155.2, 171.5. IR (KBr, cm−1) ν: 2941, 1741, 1446, 1253, 1012, 890. EI MS (70 eV) m/z 
(rel. intensity): 556 (M+, 6), 466 (73), 203 (38), 189 (100), 135 (41); Elemental anal. (%), calcd. for 
C35H56O5: C, 75.50; H, 10.14; found: C, 75.68; H, 10.04. 
3.7. Crystal Structure Determination 
X-ray diffraction measurement was performed at 100(1) K. The colorless single crystal was 
preselected under polarization microscope. The crystal was mounted on a glass capillary and cooled 
down by a cold, dry nitrogen gas stream (Oxford Cryosystem Equipment). The data were collected 
using SuperNova kappa diffractometer with Atlas CCD detector and CuKα radiation. Accurate cell 
parameters were determined and refined with CrysAlis Pro program [35]. Also for the integration of 
the collected data program CrysAlis Pro was used. The structure was solved using direct methods with 
SHELXS97 program and then refined using SHELXL-97 program [36]. Nonhydrogen atoms were 
refined with anisotropic displacement parameters. The hydrogen atoms were fixed geometrically at 
calculated distances and allowed to ride on the parent carbon or oxygen atoms. 
CCDC-873113 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge at http://www.ccdc.cam.ac.uk/conts/retrieving.html or from the Cambridge 
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Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44-1223-336033;  
E-Mail: deposit@ccdc.cam.ac.uk. 
3.8. Antiproliferative Assay in Vitro 
3.8.1. Cells 
The following established in vitro cell lines were applied: SW707 (human colorectal 
adenocarcinoma), CCRF/CEM (human leukemia), T47D (human breast cancer), P388 (mouse 
leukemia) and Balb3T3 (normal mouse fibroblasts). All lines were obtained from the American Type 
Culture Collection (Rockville, MD, USA) and maintained at the Cell Culture Collection of the 
Institute of Immunology and Experimental Therapy (Wroclaw, Poland).  
Twenty-four hours before addition of the tested agents, the cells were plated in 96-well plates 
(Sarstedt, Numbrecht, Germany) at a density of 104 cells per well in 100 μL of culture medium. The 
cells were cultured in the opti-MEM medium supplemented with 2 mM glutamine (Gibco, Grand 
Island, NY, USA), streptomycin (50 μg/mL), penicillin (50 U/mL) (both antibiotics from Polfa, 
Tarchomin, Poland) and 5% fetal calf serum (Gibco). The cell cultures were maintained at 37 C in 
humid atmosphere saturated with 5% CO2. 
3.8.2. Compounds 
The compounds were dissolved in DMSO and culture medium (1:9) to the concentration of 1 mg/mL, 
and subsequently diluted in culture medium to reach the required concentrations (ranging from 1 to 
100 mg/mL).  
3.9. Antiproliferative Assay  
The in vitro cytotoxic effect of all agents was examined using the SRB assay for adherent cells and 
MTT assay for leukemia cells as described by Wietrzyk et al. [37]. Each compound in given 
concentration was tested in triplicates in each experiment, which was repeated 3–5 times. The results 
of cytotoxic activity in vitro were expressed as an IC50 – the concentration of compound (in μg/mL) 
that inhibits proliferation rate of the tumor cells by 50% as compared to the control untreated cells. 
4. Conclusions 
New acetylenic derivatives of betulin containing one or two acetylenic formate or propynoyl 
functions at the C-3 and/or C-28 positions were synthesized. The structures of the title compounds 
were confirmed by 1H, 13C-NMR, IR, MS, and elemental analyses. Furthermore, the structure of  
28-O-propynoylbetulin (5a) was also determined by X-ray crystal analysis. The presented studies 
demonstrated that a simple modification of the parent structure of betulin (1) can produce new 
potentially interesting anti-cancer agents. Among all studied compounds, 28-O-propynoylbetulin (5a) 
exhibited the strongest cytotoxic activity and it was over 500 times more cytotoxic than betulin (1) and 
100 times more cytotoxic than cisplatin against CCRF/CEM cancer cells with promising selectivity 
index (SI = 15) under in vitro conditions. It was found that the betulins which possess a carbonyl group 
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at C-28 position directly bonded to the triple bond of an ethynyl substituent, showed strong cytotoxic 
effects against human leukemia (CCRF/CEM) and murine leukemia (P388) cancer cells. It was also 
found that the free C-3 hydroxyl function is a structural requirement for the cytotoxicity of the studied 
compounds. The compound 5a has been selected for further studies. Noteworthy feature of the 
obtained results was the observation that leukemia (CCRF/CEM and P388) cells appear to be more 
sensitive to the cytotoxic effects of the compounds 3 and 5 than the other cancer cells lines applied. 
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